Citizen Petition from Alliance to Protect Insulin Choice
Details
The document's own metadata, straight from the source system.
- Title
- Citizen Petition from Alliance to Protect Insulin Choice
- Posted
- Apr 17, 2025
- Comment period
- Apr 17, 2025 – ?
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Stance breakdown
Who commented
Breakdown by commenter type.
Comments over time
Weekly arrivals, stacked by stance.
Support × commenter type
How each type splits across stance.
Issues raised
The docket's canonical issues. Select one to browse its comments.
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
- Jun 24, 2026Comment from Christie SchumacherSupportAcademicRead comment →
- Jun 24, 2026Comment from Anders Carlson, MDSupportIndividualRead comment →
- Jun 24, 2026Comment from Ponnusamy Saravanan, ProfessorOtherAcademicRead comment →
- Jun 24, 2026Comment from Maria Ramos, MDSupportIndividualRead comment →
- Jun 20, 2026Comment from Dr. V. MohanOtherIndividualRead comment →
- Jun 20, 2026Comment from Alissa Segal, PharmDSupportAcademicRead comment →
- Jun 14, 2026Comment from Emily Rosenberg, MDSupportIndividualRead comment →
- May 20, 2026Comment from Sydney Look, MDSupportAcademic
Sydney Look, a Pediatric Endocrinology Fellow at the University of Utah, supports the petition to prioritize patient choice in insulin selection. The commenter argues that individualized care is essential for managing type 1 diabetes, particularly during pregnancy, where specific insulin analogues have different safety and efficacy profiles.
Read comment → - May 20, 2026Comment from Kara Higginson, RNSupportIndividual
Kara Higginson, a Registered Nurse, supports the petition by emphasizing the importance of maintaining Levemir as a long-lasting insulin option. She argues that Levemir is crucial for specific populations like pregnant women and athletes, and that having more options helps ensure better therapeutic outcomes and lower prices.
Read comment → - May 18, 2026Comment from Vandana RamanSupportAcademic
A pediatric endocrinologist supports the petition to preserve access to insulin detemir, noting its clinical importance for children and patients with variable insulin sensitivity. The commenter argues that some patients cannot successfully transition to other basal insulins and emphasizes the need for therapeutic choice in individualized diabetes care.
Read comment →
